Biotech firm Rubius Therapeutics gains state incentives, will open new plant

By
-
RUBIUS THERAPEUTICS was approved for a potential $9 million in tax incentives by the R.I. Commerce Corp. Thursday. The company plans to retrofit a Smithfield manufacturing facility through a $155 million investment.
RUBIUS THERAPEUTICS was approved for a potential $9 million in tax incentives by the R.I. Commerce Corp. Thursday. The company plans to retrofit a Smithfield manufacturing facility through a $155 million investment.
PROVIDENCE – R.I. Commerce Corp., the state’s economic development agency, on Thursday approved a package of tax reductions and incentives potentially worth more than $9 million for Rubius Therapeutics Inc. to open a pharmaceutical manufacturing plant in Smithfield. In return, the Cambridge, Mass.-based biotechnology company has pledged to create 160 jobs at the site with…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

RELATED ARTICLESMORE FROM AUTHOR